Regenxbio (RGNX) Interest Coverage Ratio (2014 - 2025)
Regenxbio (RGNX) recorded quarterly Interest Coverage Ratio of 4.7 in Q4 2025, down 17.97% quarter-over-quarter from 3.98 in Q3 2025, and up 13.93% on a YoY basis from 4.12 in Q4 2024.
Regenxbio (RGNX) Interest Coverage Ratio (2014 - 2025) Analysis & Trends
Regenxbio's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 4.7 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 13.93% year-over-year to 4.7; the TTM figure through Dec 2025 stood at 3.58 (up 80.57% YoY), while the FY2025 annual figure was 3.58, up 80.57% from the prior year.
- Interest Coverage Ratio was 4.7 for Q4 2025 at Regenxbio, down from 3.98 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 48.25 in Q4 2021 to a low of 124.8 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 22.44 across 5 years, with a median of 10.39 in 2022.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio tumbled 616.08% in 2023, then jumped 104.37% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 48.25 in 2021, then sank by 127.78% to 13.4 in 2022, then tumbled by 249.78% to 46.88 in 2023, then surged by 88.37% to 5.45 in 2024, then climbed by 13.93% to 4.7 in 2025.
- The last three Interest Coverage Ratio figures came in at 4.7 (Q4 2025), 3.98 (Q3 2025), and 5.76 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | -4.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.70 |
| Sep 30, 2025 | -3.98 |
| Jun 30, 2025 | -5.76 |
| Mar 31, 2025 | 1.42 |
| Dec 31, 2024 | -5.45 |
| Sep 30, 2024 | -75.70 |
| Jun 30, 2024 | -124.80 |
| Mar 31, 2024 | -32.37 |
| Dec 31, 2023 | -46.88 |
| Sep 30, 2023 | -40.00 |
| Jun 30, 2023 | -65.28 |
| Mar 31, 2023 | -24.01 |
| Dec 31, 2022 | -13.40 |
| Sep 30, 2022 | -11.93 |
| Jun 30, 2022 | -9.12 |
| Mar 31, 2022 | -11.67 |
| Dec 31, 2021 | 48.25 |
| Sep 30, 2021 | -8.55 |
| Jun 30, 2021 | -8.20 |
| Mar 31, 2021 | -6.57 |